Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect

Clinical trial NCT00003425 · COMPLETED

Trial details

NCT number: NCT00003425
Sponsor: University of Kentucky
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer Leukemia Lymphoma Neuroblastoma Ovarian Cancer Sarcoma Unspecified Adult Solid Tumor, Protocol Specific

Start date: 1997-12-01
Primary completion: 2002-07-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.